| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.18 | 0.005 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.14 | 0.009 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.13 | 0.03 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.093 | 0.06 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.092 | 0.07 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.084 | 0.09 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.085 | 0.1 |